Cite
HARVARD Citation
Owen, R. et al. (2020). Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study. Lancet. 7 (2), pp. e112-e121. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Owen, R. et al. (2020). Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study. Lancet. 7 (2), pp. e112-e121. [Online].